title: Long-term metformin use is associated with decreased risk of breast cancer.
authors.affiliation: Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland.
authors.forename: Michael
authors.initials: M
authors.lastname: Bodmer
authors.forename: Christian
authors.initials: C
authors.lastname: Meier
authors.forename: Stephan
authors.initials: S
authors.lastname: Krähenbühl
authors.forename: Susan S
authors.initials: SS
authors.lastname: Jick
authors.forename: Christoph R
authors.initials: CR
authors.lastname: Meier
mesh_terms: D000368:Aged; D001943:Breast Neoplasms / Q000453:epidemiology*; D016022:Case-Control Studies; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008687:Metformin / Q000627:therapeutic use*; D008875:Middle Aged; D016017:Odds Ratio; D013997:Time Factors
chemical_list: D007004:Hypoglycemic Agents; D008687:Metformin